| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.32 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.33 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |